Clofazimine: an old drug for never-ending diseases

Clofazimine (CFZ), an old hydrophobic riminophenazine, has a wide range of antimycobacterial activity ranging from leprosy to nontuberculous mycobacterial diseases. CFZ has several advantages such as a favorable pharmacokinetic profile, dose-dependent side effects as well as low price. In this narra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future microbiology Jg. 15; H. 7; S. 557 - 566
Hauptverfasser: Riccardi, Niccolò, Giacomelli, Andrea, Canetti, Diana, Comelli, Agnese, Intini, Enrica, Gaiera, Giovanni, Diaw, Mama M, Udwadia, Zarir, Besozzi, Giorgio, Codecasa, Luigi, Biagio, Antonio Di
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Future Medicine Ltd 01.05.2020
Schlagworte:
clofazimine
leprosy
MDR-TB
NTM
XDR-TB
ISSN:1746-0913, 1746-0921, 1746-0921
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Clofazimine (CFZ), an old hydrophobic riminophenazine, has a wide range of antimycobacterial activity ranging from leprosy to nontuberculous mycobacterial diseases. CFZ has several advantages such as a favorable pharmacokinetic profile, dose-dependent side effects as well as low price. In this narrative review, we have assessed the clinical development of CFZ, starting from the potential mechanism of actions, to the spectrum of side effects and potential drug–drug interactions, highlighting its current place in therapy and future possible use in leprosy, nontuberculous mycobacterial diseases and drug-resistant tuberculosis.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1746-0913
1746-0921
1746-0921
DOI:10.2217/fmb-2019-0231